Risk of Cardiorespiratory Events Following Respiratory Syncytial Virus-Related Hospitalization. [PDF]
Liang C +8 more
europepmc +1 more source
Cost-Effectiveness Analysis of Clesrovimab for Respiratory Syncytial Virus in Infants in the United States. [PDF]
Kura K +7 more
europepmc +1 more source
Respiratory Syncytial Virus Epidemiology in Transition: Five Years of Profound Change. [PDF]
Castagno E, Raffaldi I.
europepmc +1 more source
Incidence of respiratory syncytial virus and influenza: A Danish nationwide cohort study. [PDF]
Fonseca MJ +10 more
europepmc +1 more source
Human telomerase reverse transcriptase supports respiratory syncytial virus replication. [PDF]
Huynh H, Wu CT, Kahn JS.
europepmc +1 more source
Atrial Fibrillation After Respiratory Syncytial Virus Vaccination Among Older Adults. [PDF]
Birabaharan M +4 more
europepmc +1 more source
Establishment of a Dual-Reporter Minigenome System for Respiratory Syncytial Virus. [PDF]
Pan L, Xu Y, Ma Y, Zhang J, Wu C.
europepmc +1 more source
Severity and Cost of Respiratory Syncytial Virus Versus Influenza in Hospitalized Adults in Spain. [PDF]
Correcher-Martínez E +8 more
europepmc +1 more source
Evaluation of respiratory syncytial virus (RSV) vaccine eligibility in an outpatient adult infectious diseases clinic. [PDF]
Liu A, Stack C, Mahoney MV.
europepmc +1 more source

